FGF2 and neoplasm: Among the tumor-promoting cytokines, we observed a decrease in the levels of the pro-angiogenic and pro-inflammatory cytokines GRO-alpha (by 192%), VEGF (by 34%), IL-6 (by 176%), IL-8 (by 204%), and RANTES (by 16%), and an increase in other cytokines, such as eotaxin-2 (by 8%), eotaxin-3 (by 6%), IL-1β (by 24%), MIG (by 18%), TNFα (by 36%), TGF-beta1 (by 21%), and -beta3 (by 34%), bFGF (by 15%), TRAIL-R3 (by 11%), and TRAIL-R4 (by 15%).